Published in J Infect on July 01, 1992
Epidemiology of nosocomial fungal infections. Clin Microbiol Rev (1996) 5.03
Fatal, disseminated Acremonium strictum infection in a neutropenic host. J Clin Microbiol (1996) 1.03
Fatal endocarditis in a neonate caused by the dematiaceous fungus Phialemonium obovatum: case report and review of the literature. J Clin Microbiol (2002) 0.93
Evaluation of the efficacies of Amphotericin B, Posaconazole, Voriconazole, and Anidulafungin in a murine disseminated infection by the emerging opportunistic Fungus Sarocladium (Acremonium) kiliense. Antimicrob Agents Chemother (2013) 0.87
Catheter-Related Acremonium kiliense Fungemia in a Patient with Ulcerative Colitis under Treatment with Infliximab. Case Rep Infect Dis (2011) 0.75
Effect of nesiritide in patients with acute decompensated heart failure. N Engl J Med (2011) 7.62
Enhanced differentiation of isolates of Candida albicans using a modified resistogram method. Mykosen (1982) 7.04
Itraconazole resistance in Aspergillus fumigatus. Antimicrob Agents Chemother (1997) 4.75
Antifungal susceptibility testing: practical aspects and current challenges. Clin Microbiol Rev (2001) 4.49
Efficacy of superovulation and intrauterine insemination in the treatment of infertility. National Cooperative Reproductive Medicine Network. N Engl J Med (1999) 4.42
Fluconazole resistance in Candida glabrata. Lancet (1988) 4.05
Fluconazole resistance in Candida glabrata. Antimicrob Agents Chemother (1993) 4.04
Sperm morphology, motility, and concentration in fertile and infertile men. N Engl J Med (2001) 3.97
Trends in mortality due to invasive mycotic diseases in the United States, 1980-1997. Clin Infect Dis (2001) 3.68
Quality-of-life changes and hearing impairment. A randomized trial. Ann Intern Med (1990) 3.52
Correlation between in-vitro susceptibility testing to itraconazole and in-vivo outcome of Aspergillus fumigatus infection. J Antimicrob Chemother (1997) 3.40
Standardized susceptibility testing of fluconazole: an international collaborative study. Antimicrob Agents Chemother (1992) 3.19
Resistogram method for differentiation of strains of Candida albicans. J Appl Bacteriol (1979) 2.97
Correlation of MIC with outcome for Candida species tested against voriconazole: analysis and proposal for interpretive breakpoints. J Clin Microbiol (2006) 2.86
Emergence of azole drug resistance in Candida species from HIV-infected patients receiving prolonged fluconazole therapy for oral candidosis. J Antimicrob Chemother (1995) 2.83
Vaginal candidiasis and the role of the digestive tract as a source of infection. Br J Obstet Gynaecol (1975) 2.76
In vitro studies of activity of voriconazole (UK-109,496), a new triazole antifungal agent, against emerging and less-common mold pathogens. Antimicrob Agents Chemother (1997) 2.75
Aspergillus antigen latex test for diagnosis of invasive aspergillosis. Lancet (1991) 2.59
Disruption of the sarcoglycan-sarcospan complex in vascular smooth muscle: a novel mechanism for cardiomyopathy and muscular dystrophy. Cell (1999) 2.57
In-vitro resistance to imidazole antifungals in Candida albicans. J Antimicrob Chemother (1984) 2.43
Candida dubliniensis fungemia: the first four cases in North America. Emerg Infect Dis (2000) 2.34
Mechanisms and clinical impact of antifungal drug resistance. J Med Vet Mycol (1994) 2.32
Incidence of invasive aspergillosis following hematopoietic stem cell and solid organ transplantation: interim results of a prospective multicenter surveillance program. Med Mycol (2005) 2.29
Molecular biological characterization of an azole-resistant Candida glabrata isolate. Antimicrob Agents Chemother (1997) 2.27
Quantitation of Candida albicans ergosterol content improves the correlation between in vitro antifungal susceptibility test results and in vivo outcome after fluconazole treatment in a murine model of invasive candidiasis. Antimicrob Agents Chemother (2000) 2.22
Azole resistance in Candida albicans. J Med Vet Mycol (1986) 2.17
An intermeniscal fibrous band in a recreational runner. Arthroscopy (1995) 2.01
In-vitro activity of voriconazole, itraconazole and amphotericin B against filamentous fungi. J Antimicrob Chemother (1998) 1.98
Sonographic and Doppler characteristics of the corpus luteum: can they predict pregnancy outcome? J Ultrasound Med (2001) 1.98
Typing of Candida albicans. J Hosp Infect (1984) 1.93
Clinical pharmacokinetics of systemic antifungal drugs. Clin Pharmacokinet (1983) 1.88
Comparison of E-test and broth microdilution methods for antifungal drug susceptibility testing of molds. J Clin Microbiol (1999) 1.85
Pharmacokinetics of ketoconazole in normal subjects. J Antimicrob Chemother (1981) 1.84
Multicenter evaluation of Microring YT, a new method of yeast identification. J Clin Microbiol (1990) 1.83
Epidemiology, clinical manifestations, and therapy of infections caused by dematiaceous fungi. J Chemother (2003) 1.75
Nephrotoxicity of ionic and nonionic contrast media in 1196 patients: a randomized trial. The Iohexol Cooperative Study. Kidney Int (1995) 1.74
Computer-assisted rapid enzyme-linked immunosorbent assay (ELISA) in the serological diagnosis of aspergillosis. J Immunol Methods (1983) 1.70
Epidemiological investigation of patients with vulvovaginal candidosis. Application of a resistogram method for strain differentiation of Candida albicans. Br J Vener Dis (1979) 1.70
Trends in antifungal drug susceptibility of Cryptococcus neoformans isolates in the United States: 1992 to 1994 and 1996 to 1998. Antimicrob Agents Chemother (2001) 1.70
A randomized controlled trial of itraconazole versus fluconazole for the prevention of fungal infections in patients with haematological malignancies. U.K. Multicentre Antifungal Prophylaxis Study Group. Br J Haematol (1999) 1.66
Association between hearing impairment and the quality of life of elderly individuals. J Am Geriatr Soc (1990) 1.65
Cardiomyocyte death: mechanisms and translational implications. Cell Death Dis (2011) 1.61
In vitro activities of voriconazole, itraconazole, and amphotericin B against Blastomyces dermatitidis, Coccidioides immitis, and Histoplasma capsulatum. Antimicrob Agents Chemother (2000) 1.59
Immunology and endometriosis. Fertil Steril (1992) 1.56
Bioassays for itraconazole blood levels: an interlaboratory collaborative study. J Antimicrob Chemother (1999) 1.52
Evaluation of the AUXACOLOR system, a new method of clinical yeast identification. J Clin Pathol (1995) 1.51
Fungal nail disease: a guide to good practice (report of a Working Group of the British Society for Medical Mycology). BMJ (1995) 1.50
Comparison of a new commercial colorimetric microdilution method with a standard method for in-vitro susceptibility testing of Candida spp. and Cryptococcus neoformans. J Antimicrob Chemother (1998) 1.50
Lack of correlation of in vitro amphotericin B susceptibility testing with outcome in a murine model of Aspergillus infection. J Antimicrob Chemother (2000) 1.50
Notch signalling suppresses apoptosis in adult human and mouse pancreatic islet cells. Diabetologia (2007) 1.49
Effectiveness of percutaneous balloon valvuloplasty in adults with pulmonic valve stenosis. Am J Cardiol (1991) 1.49
Azole drug resistance in Candida species. J Med Microbiol (1992) 1.49
Progesterone-induced immunosuppression is not mediated through the progesterone receptor. Hum Reprod (1996) 1.48
Targeted replacement of KV1.5 in the mouse leads to loss of the 4-aminopyridine-sensitive component of I(K,slow) and resistance to drug-induced qt prolongation. Circ Res (2001) 1.45
Theophylline for the treatment of atrioventricular block after myocardial infarction. Ann Intern Med (1995) 1.45
Effect of simultaneous oral and vaginal treatment on the rate of cure and relapse in vaginal candidosis. Br J Vener Dis (1979) 1.44
Modified response to ketoconazole of Candida albicans from a treatment failure. Lancet (1983) 1.43
Effects of treatment on outcome in mildly symptomatic patients with ischemia during daily life. The Atenolol Silent Ischemia Study (ASIST) Circulation (1994) 1.43
Adenosine: diagnostic and therapeutic uses in cardiovascular medicine. Chest (1993) 1.43
Treatment of hepatic candidosis with liposomal amphotericin B in patient with acute leukaemia. Lancet (1991) 1.42
Anatomic factors associated with recurrent pregnancy loss. Semin Reprod Med (2000) 1.41
Antibacterial activity and mechanism of action of 3'-azido-3'-deoxythymidine (BW A509U). Antimicrob Agents Chemother (1987) 1.41
Single-stage coronary angiography and angioplasty: a new standard? Am J Cardiol (1995) 1.39
Developmental regulation of nicotinic ACh receptor subunit mRNAs in the rat central and peripheral nervous systems. J Neurosci (1995) 1.38
Molecular epidemiological study of Aspergillus fumigatus in a bone marrow transplantation unit by PCR amplification of ribosomal intergenic spacer sequences. J Clin Microbiol (1998) 1.37
Gastrointestinal basidiobolomycosis in Arizona: clinical and epidemiological characteristics and review of the literature. Clin Infect Dis (2001) 1.36
Significance of leukemia clusters. J Pediatr (1968) 1.35
Management of persistent vulvo vaginal candidosis due to azole-resistant Candida glabrata. Genitourin Med (1993) 1.35
Multiple dose pharmacokinetics of ketoconazole and their effects on antipyrine kinetics in man. J Antimicrob Chemother (1983) 1.34
Influence of tart cherry juice on indices of recovery following marathon running. Scand J Med Sci Sports (2010) 1.31
Influence of food on the pharmacokinetics of ketoconazole. Antimicrob Agents Chemother (1984) 1.31
Comparison of in vitro antifungal activities of free and liposome-encapsulated nystatin with those of four amphotericin B formulations. Antimicrob Agents Chemother (1998) 1.31
The transient outward current in mice lacking the potassium channel gene Kv1.4. J Physiol (1998) 1.30
Localization of nAChR subunit mRNAs in the brain of Macaca mulatta. Eur J Neurosci (2000) 1.29
Mucin genes expressed by human female reproductive tract epithelia. Biol Reprod (1997) 1.29
Azole drug resistance in yeasts. J Antimicrob Chemother (1995) 1.28
Intra- and interlaboratory study of a method for testing the antifungal susceptibilities of dermatophytes. J Clin Microbiol (2004) 1.26
Guidelines for the investigation of invasive fungal infections in haematological malignancy and solid organ transplantation. British Society for Medical Mycology. Eur J Clin Microbiol Infect Dis (1997) 1.25
Rapid enzyme-linked immunosorbent assay (ELISA) for Aspergillus fumigatus antibodies. J Clin Pathol (1982) 1.24
Report of the first human case of lobomycosis in the United States. J Clin Microbiol (2000) 1.22
Complications of posterolateral dislocation of the knee: case report and literature review. Clin Orthop Relat Res (1981) 1.22
Percutaneous transluminal coronary angioplasty in acute myocardial infarction. Am Heart J (1984) 1.21
Comparison of the API Candida system with the AUXACOLOR system for identification of common yeast pathogens. J Clin Microbiol (1999) 1.21
Resistogram typing of Candida albicans isolates from oral and cutaneous sites in irradiated patients. Sabouraudia (1985) 1.20
Multiple dose pharmacokinetics of an oral solution of itraconazole in autologous bone marrow transplant recipients. J Antimicrob Chemother (1994) 1.20
Clinical pharmacokinetics of ketoconazole. Clin Pharmacokinet (1988) 1.20
Use of the Pastorex aspergillus antigen latex agglutination test for the diagnosis of invasive aspergillosis. J Clin Pathol (1995) 1.18
Na+-Ca2+ exchanger remodeling in pressure overload cardiac hypertrophy. J Biol Chem (2001) 1.18
Electrical remodeling in pressure-overload cardiac hypertrophy: role of calcineurin. Circulation (2001) 1.17
Comparison of the multiple dose pharmacokinetics of two formulations of itraconazole during remission induction for acute myeloblastic leukaemia. J Antimicrob Chemother (1991) 1.17
Azole drug resistance as a cause of clinical relapse in AIDS patients with cryptococcal meningitis. Int J STD AIDS (1996) 1.16
Counterpoint: invasive aspergillosis and the environment--rethinking our approach to prevention. Clin Infect Dis (2001) 1.15
Multiple dose pharmacokinetics of an oral solution of itraconazole in patients receiving chemotherapy for acute myeloid leukaemia. J Antimicrob Chemother (1995) 1.14
Evaluation of a new slide latex agglutination test for diagnosis of vaginal candidosis. Eur J Clin Microbiol (1987) 1.14
The Amount of MUC5B mucin in cervical mucus peaks at midcycle. J Clin Endocrinol Metab (2001) 1.13
Epidemiologic determinants of endometriosis: a hospital-based case-control study. Ann Epidemiol (1997) 1.12
Outcome of pregnancies in women with uterine leiomyomas identified by sonography in the first trimester. J Clin Ultrasound (2001) 1.10
Comparative evaluation of FUNGITEST and broth microdilution methods for antifungal drug susceptibility testing of Candida species and Cryptococcus neoformans. J Clin Microbiol (1998) 1.09
Sporothrix schenckii sensitivity to voriconazole, itraconazole and amphotericin B. Med Mycol (2001) 1.09
MUC4 and MUC5B transcripts are the prevalent mucin messenger ribonucleic acids of the human endocervix. Biol Reprod (1999) 1.07